NC
ERAS icon

Nokomis Capital’s Erasca ERAS Stock Holding History

Nokomis Capital’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-137,877
Closed -$294K – 55
2023
Q4 		$294K Buy
+137,877
New +$291K 0.09% 40

Other funds holding ERAS

AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Nokomis Capital's ERAS Position: Q1 2024 in Review

Nokomis Capital sold out of Erasca (ERAS) in Q1 2024, closing a stake of 137,877 shares — an estimated $294K sold.

Nokomis Capital first reported a position in ERAS in Q4 2023 and held it in 1 quarter. The position peaked at $294K in Q4 2023. 108 funds tracked by Wall St. Rank hold ERAS as of Q1 2024.

  • Nokomis Capital reported no remaining Erasca position as of Q1 2024 after selling out during the quarter.
  • Nokomis Capital sold 137,877 Erasca shares in Q1 2024, an estimated $294K.
  • Nokomis Capital first reported a position in Erasca in Q4 2023 and held it in 1 quarter.
  • Nokomis Capital's Erasca position peaked at $294K in Q4 2023.
  • 108 funds tracked by Wall St. Rank held Erasca as of Q1 2024.

Based on Nokomis Capital's 13F filing for Q1 2024, filed 14 May 2024.